Stericycle

Stericycle is an American compliance and environmental-services company specializing in the collection, treatment, transportation, and disposal of regulated medical waste. Its core activities include handling sharps, pharmaceutical and controlled-substance waste, trace chemotherapy waste, pathological waste, and other materials subject to healthcare and environmental regulation. The company also supplies sharps containers and related collection equipment, provides drug-disposal programs, and offers training and compliance tools for healthcare organizations. Stericycle was established in 1989 by Dr. James Sharp in response to the public-health concerns associated with the so-called Syringe Tide, when discarded medical needles and other healthcare waste washed onto beaches in the New York and New Jersey area. The resulting regulatory attention, including the United States Medical Waste Tracking Act of 1988, helped create demand for specialized medical-waste services. Mark Miller became president and chief executive in 1992, and the company expanded rapidly under his leadership. Stericycle completed an initial public offering on NASDAQ in 1996 under the symbol SRCL. The company broadened its scope during the 1990s and 2000s through acquisitions, new service lines, and international expansion. Its offerings grew from regulated medical-waste collection into sharps management, hazardous-waste services, pharmaceutical and controlled-substance disposal, compliance education, and integrated waste-stream management. In 2010, Stericycle entered communications-related services through its acquisition of NotifyMD. Its 2015 acquisition of Shred-it for approximately $2.3 billion added secure information destruction, including paper shredding and hard-drive destruction, and made Stericycle a broader compliance-services provider for healthcare institutions and businesses. Stericycle serves hospitals, physician and dental practices, blood banks, pharmaceutical manufacturers, veterinary facilities, funeral homes, outpatient and long-term-care providers, laboratories, retailers, manufacturers, and other organizations that generate regulated waste or sensitive information. Its service footprint has changed over time. Full service offerings have been available in the United States, Canada, Ireland, Spain, and Portugal; the United Kingdom has offered a narrower range that excludes hazardous-waste management; and several continental European markets have focused principally on secure information destruction. The company has exited a number of former international markets. During the COVID-19 pandemic, Stericycle transported, treated, and disposed of potentially infectious materials and developed disposal options for personal protective equipment. In 2021, it worked with UPS Healthcare on reverse logistics for medical waste. It has also promoted safe prescription-drug disposal through mail-back programs and public-health partnerships addressing opioid misuse. Stericycle faced environmental, operational, and litigation controversies during its independent corporate history. These included regulatory proceedings concerning emissions and waste treatment at particular facilities, a major customer class-action settlement concerning billing practices, a dispute over an NHS clinical-waste contract in England, and UK collection disruptions during the pandemic. In June 2024, the company agreed to be acquired by WM for approximately $7.2 billion. The transaction closed in November 2024, ending Stericycle's separate NASDAQ listing and making it a wholly owned WM subsidiary. In January 2025, Urbaser completed the purchase of Stericycle's biosanitary-waste businesses in Spain and Portugal.

Stericycle emerged from the regulatory and public-health concerns surrounding medical waste disposal in the United States during the late 1980s. Its founding in 1989 by Dr. James Sharp followed the Syringe Tide, when discarded needles and related healthcare waste appeared on beaches along the New York and New Jersey coast. The episode helped establish the need for controlled collection and treatment systems, while the Medical Waste Tracking Act of 1988 provided an important regulatory backdrop for the developing industry. Mark Miller became president and chief executive in 1992. Under his leadership, Stericycle expanded its customer base and developed a nationwide operating model for regulated medical waste. The company went public on NASDAQ in 1996 under the symbol SRCL. International growth began in 1997 through a joint venture in Mexico. In 1999, Stericycle acquired approximately 200,000 customers from Allied Waste Industries after Allied acquired Browning-Ferris Industries. That year it also introduced the Steri-Safe OSHA Compliance program, marking a move beyond physical waste collection into healthcare compliance education and training. The company expanded its service portfolio during the 2000s. In 2003 it entered sharps-waste management through the acquisition of Scherer Healthcare's existing practice. In 2004 it began offering medical-waste disposal services in the United Kingdom. It later added hazardous-waste capabilities, including through its first hazardous-waste acquisition in 2008, and entered communications solutions through the acquisition of NotifyMD in 2010. The 2014 purchase of PSC Environmental Solutions, reported at approximately $275 million, supported the formal development of Stericycle Environmental Solutions. Stericycle's largest expansion occurred in 2015, when it acquired Shred-it for approximately $2.3 billion. The transaction added secure destruction of paper records, hard drives, and other sensitive information. This broadened Stericycle's identity from a medical-waste specialist into a wider compliance-services company serving healthcare providers, manufacturers, retailers, and small businesses. The independent company also encountered operational and regulatory challenges. In England, it lost a clinical-waste contract covering general practices and pharmacies in Cumbria and northeast England after a competitor submitted a substantially lower bid. Stericycle challenged the award, but the High Court dismissed the case in 2018; related litigation ended in a confidential settlement in 2019. In the United States, regulators investigated waste-treatment and air-emissions issues at specific facilities. A 2014 Utah agreement concerning the North Salt Lake incinerator required a relocation commitment and imposed a fine, while the facility ultimately closed in 2022. These events shaped scrutiny of the environmental risks associated with medical-waste incineration. Stericycle continued developing container products, disposal logistics, and public-health programs. In 2022 it introduced the SafeShield antimicrobial medical-waste container as part of an effort to simplify and reduce the number of container types used across its operations. During the COVID-19 pandemic, it handled potentially infectious waste and offered solutions for personal protective equipment. A 2021 collaboration with UPS Healthcare addressed reverse logistics for medical waste. The company also developed medication mail-back programs and worked with public-health organizations on opioid-disposal campaigns. In June 2024, Stericycle agreed to be acquired by WM for approximately $7.2 billion. The acquisition closed in November 2024, making Stericycle a wholly owned subsidiary and ending its independent listing. In January 2025, Urbaser completed the purchase of Stericycle's biosanitary-waste businesses in Spain and Portugal. The transaction marked a further adjustment of the company's international operating footprint under its new ownership.

1. 2025Urbaser acquires Iberian biosanitary operations

   Urbaser completes the acquisition of Stericycle's biosanitary businesses in Spain and Portugal.

   Source
2. 2024WM acquisition announced and completed

   WM agrees to acquire Stericycle and completes the transaction in November.

   Source
3. 2022SafeShield container introduced

   Stericycle releases an antimicrobial regulated-medical-waste container.

   Source
4. 2021UPS Healthcare reverse-logistics partnership

   Stericycle and UPS Healthcare collaborate on transportation and disposal logistics for medical waste.

   Source
5. 2015Shred-it acquisition

   Stericycle acquires Shred-it, adding secure document and hard-drive destruction.

   Source
6. 2010Communications Solutions is established

   The acquisition of NotifyMD adds a communications-services business line.

   Source
7. 2003Entry into sharps management

   Stericycle acquires Scherer Healthcare's sharps-waste practice.

   Source
8. 1999Steri-Safe compliance program launches

   Stericycle adds structured OSHA compliance education and training services.

   Source
9. 1997International expansion begins

   The company begins international operations through a joint venture in Mexico.

   Source
10. 1996NASDAQ listing

    Stericycle becomes publicly traded on NASDAQ under ticker SRCL.

    Source
11. 1992Mark Miller becomes president and CEO

    Mark Miller takes the company's top operating role during its major growth period.

    Source
12. 1989Stericycle is founded

    Dr. James Sharp establishes Stericycle to address the emerging need for specialized medical-waste management.

    Source

A specialized, regulation-focused provider combining healthcare waste management, compliance support, pharmaceutical disposal, and secure information destruction.

• Regulated Medical Waste ManagementMedical-waste services1989

  Collection, transportation, treatment, and disposal services for regulated healthcare waste. Materials may include infectious waste, pathological waste, trace chemotherapy waste, and other streams requiring controlled handling. Customers include hospitals, clinics, laboratories, blood banks, veterinary facilities, and long-term-care organizations.

• Sharps ManagementMedical-waste services2003

  Specialized containers, pickup, transportation, and treatment for needles, syringes, and other sharps. The service is intended to reduce needlestick exposure and support compliance with healthcare safety requirements.

• Pharmaceutical and Drug DisposalPharmaceutical-waste services

  Programs for the controlled collection and destruction of unused, expired, or otherwise unwanted medicines, including controlled substances and environmentally persistent pharmaceutical pollutants. Offerings include institutional services and consumer mail-back programs in selected markets.

• Shred-itSecure information destruction2015

  Secure destruction of paper records, electronic media, and hard drives. Added through the 2015 acquisition of Shred-it, the offering extends Stericycle's compliance proposition to information-security and records-management risks.

• Steri-SafeCompliance training1999

  Compliance education and training focused initially on OSHA-related healthcare requirements and later on broader topics such as information security, human resources, medical billing, and regulatory practice.

• SafeShieldMedical-waste container2022

  An antimicrobial medical-waste container introduced in 2022 for the storage and transportation of regulated medical waste. It formed part of Stericycle's effort to consolidate a large range of container formats into a smaller standardized portfolio.

• 2022Arbor Day Foundation tree-planting partnership

  North America · United Kingdom

  Stericycle partnered with the Arbor Day Foundation on tree planting during 2022 and 2023.

  Outcome. More than 120,000 trees were reported planted across North America and the United Kingdom.

  Source
• 2021National Park Foundation conservation partnership

  United States

  Stericycle announced a five-year, $1 million commitment supporting habitat and wetland conservation in national-park settings.

  Outcome. Supported restoration projects including work associated with Timucuan Ecological and Historic Preserve and Cumberland Island National Seashore.

  Source
• 2020Rural medication mail-back initiative

  United States

  Stericycle worked with the Rural Community Assistance Partnership to distribute 10,000 medication mail-back envelopes in rural communities.

  Outcome. Improved access to regulated disposal for unused prescription drugs.

  Source
• 2019Opioids at Work Employer Toolkit

  United States

  Stericycle and the National Safety Council launched workplace resources addressing opioid misuse and employer response.

  Outcome. Provided employers with educational and prevention materials.

  Source
• 2018National Safety Council medication-disposal partnership

  United States

  Stericycle became a medication-disposal partner of the National Safety Council and distributed Seal&Send mail-back envelopes to encourage safe destruction of unused medicines.

  Outcome. Expanded public awareness and access to regulated medication disposal.

  Source
• 2018Stop Everyday Killers

  United States

  Stericycle supported a National Safety Council opioid-awareness initiative that included the Prescribed to Death memorial exhibit in Chicago.

  Outcome. Used public education and memorialization to draw attention to prescription-opioid deaths and safe disposal.

  Source

• 2024Agreement to be acquired by WMM&A

  Stericycle agreed to combine with WM as part of a strategic change in ownership.

  What changed. WM agreed to acquire Stericycle for approximately $7.2 billion, and the transaction closed in November 2024.

  Aftermath. Stericycle became a wholly owned subsidiary of WM and ceased to be separately listed on NASDAQ.

  Acquisition value. $7.2 billion (2024)

  Source
• 2022SafeShield container launchProduct launch

  Stericycle was redesigning its container portfolio to simplify procurement and standardize regulated-waste handling.

  What changed. The company introduced the SafeShield antimicrobial medical-waste container.

  Aftermath. The product supported the stated objective of reducing the number of container types used across the business.

  Source
• 2015Acquisition of Shred-itM&A

  Stericycle sought to expand beyond healthcare waste into secure information destruction and related compliance services.

  What changed. The company acquired Shred-it for approximately $2.3 billion.

  Aftermath. Stericycle added paper shredding, hard-drive destruction, and broader information-security services to its portfolio.

  Acquisition consideration. $2.3 billion (2015)

  Source
• 2014Settlement and relocation of North Salt Lake incineratorStrategy

  Utah regulators pursued enforcement related to emissions from Stericycle's North Salt Lake medical-waste incinerator.

  What changed. Stericycle reached an agreement with the Utah Division of Air Quality that required relocation of the facility and imposed a $2.3 million fine, with part potentially forgivable if relocation occurred within the specified period.

  Aftermath. The North Salt Lake incinerator was shut down in 2022.

  Regulatory fine. $2.3 million (2014)

  Source

• 2020UK clinical-waste collection failuresControversy

  Stericycle reported capacity constraints in England during the COVID-19 period and failed to complete routine collections at numerous general practices, amid unexpectedly high volumes of clinical waste and personal protective equipment.

  Source
• 2017Customer billing class actionControversy

  A nationwide customer class action alleged that Stericycle used recurring automatic price increases that could raise invoices by as much as 18 percent every six months. A $295 million settlement was reported in 2017.

  Source
• 2013North Salt Lake emissions investigationControversy

  Utah authorities investigated alleged emissions above permitted levels and alleged manipulation of reporting related to mercury, dioxins, and other substances from a medical-waste incinerator. Stericycle later reached a settlement without admitting wrongdoing.

  Source
• 2011Texas pathological-waste treatment caseControversy

  Texas regulators alleged that Stericycle failed to dispose of pathological waste according to approved methods. The company denied the allegations and agreed to a settlement that included a $34,000 fine.

  Source

• 2025Urbaser completes purchase of Stericycle businesses in Spain and Portugal

  Urbaser completed its acquisition of Stericycle's biosanitary-waste operations in Spain and Portugal.

  M&A
  Source
• 2024Stericycle agrees to acquisition by WM

  Stericycle accepted WM's offer to acquire the company for approximately $7.2 billion.

  M&A
  Source
• 2024WM completes acquisition of Stericycle

  The transaction closed in November 2024, making Stericycle a wholly owned subsidiary of WM and ending its separate public-market status.

  M&A
  Source
• 2020Stericycle faces UK clinical-waste collection disruption

  The company reported capacity problems and missed collections at numerous English medical practices during a period of increased pandemic-related waste volumes.

  Other
  Source

1. Stericycle